Merck to Acquire Acceleron Pharma Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $11.5 Billion, Deal Brings in Potential Blockbuster in PAH Says Analyst
September 30, 2021 7:56 AM EDTMerck (NYSE: MRK) announced today that it has agreed to acquire Acceleron Pharma (Nasdaq: XLRN) for $180 per share in cash in the deal valued at $11.5 billion.
Todays announcement has confirmed media reports that XLRN is in advanced talks with MRK over a takeover deal.
Strategic business development is a top... More



